News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kazam Joshua A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2022 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 34,000 options to buy
@ $3.53, valued at
$120k
|
|
| 06/17/2022 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 44,178 shares
@ $0 |
|
| 03/09/2022 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 412,618 shares
@ $0
Gifted 412,618 shares
@ $0 |
|
| 03/09/2022 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Gifted 211,000 shares
@ $0 |
|
| 01/14/2022 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Bought 15,000 shares
@ $12.6, valued at
$189k
|
|
| 06/23/2021 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 20,600 options to buy
@ $24.18, valued at
$498.1k
|
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Tishman Speyer Innovation Corp. II|
Txns:
| Bought 25,000 shares
@ $0
Bought 5,000 options to buy
@ $0 |
|
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2020 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 9,969 shares
@ $0 |
|
| 04/28/2020 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 8,039 shares
@ $0 |
|
| 03/11/2020 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 8,217 shares
@ $0 |
|
| 12/31/2019 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Diamond Eagle Acquisition Corp. \ DE|
Txns:
| Acquired 20,000 options to buy
@ $0.0001, valued at
$2 |
|
| 11/21/2019 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 8,217 shares
@ $0
Gifted 446,623 shares
@ $0 |
|
| 10/29/2019 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 8,217 shares
@ $0 |
|
| 09/25/2019 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 8,217 shares
@ $0 |
|
| 09/09/2019 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 8,217 shares
@ $0 |
|
| 07/22/2019 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 8,217 shares
@ $0 |
|
| 07/12/2019 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 5,590 shares
@ $0 |
|
| 06/24/2019 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 16,377 shares
@ $0 |
|
| 03/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2019 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Platinum Eagle Acquisition Corp.|
Txns:
| Bought 20,000 options to buy
@ $0.0031, valued at
$62 |
|
| 10/17/2018 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Converted 18,716 shares
@ $0
Converted 3,565 convertible preferred
@ $0 |
|
| 01/18/2018 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Platinum Eagle Acquisition Corp.|
Txns:
| Granted 333,334 options to buy
@ $1.5, valued at
$500k
|
|
| 01/04/2018 |
4
| Kazam Joshua A (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 18,000 options to buy
@ $1.57, valued at
$28.3k
|
|
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2017 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Granted 2,410 shares
@ $0
Granted 8,810 options to buy
@ $91.21, valued at
$803.6k
|
|
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/03/2016 |
4
| Kazam Joshua A (Director) has filed a Form 4 on Kite Pharma, Inc. |
| 04/02/2012 |
4
| Kazam Joshua A (President & CEO) has filed a Form 4 on Nile Therapeutics, Inc.|
Txns:
| Bought 125,000 shares
@ $0
Bought 93,750 warrants
@ $0.5, valued at
$46.9k
|
|
| 05/12/2011 |
4
| Kazam Joshua A (CEO) has filed a Form 4 on Nile Therapeutics, Inc. |
|
|
|